Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID M BARATZ

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1104879436
CMS profile
140605
Location
PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$5,215.10

213 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,837.17 209
Education $377.93 4

By paying entity

PY2025 · entire year · sorted by reported total

Page 4 of 5; records 151–200 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID M BARATZ

NPI 1104879436 · CMS profile ID 140605

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 5; records 151–200 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1104879436?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID M BARATZ, NPI 1104879436, CMS profile ID 140605. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104879436?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). DAVID M BARATZ, NPI 1104879436, CMS profile ID 140605. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104879436?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
DAVID M BARATZ, NPI 1104879436, CMS profile ID 140605, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 5; records 151–200 of 213 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1104879436?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

213 matching records · $5,215.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 213 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 213.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Philips North America LLC $26.1804/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232610240 CMS
AstraZeneca Pharmaceuticals LP $15.8704/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206218108 CMS
Baxter Healthcare $17.8704/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1180962878 CMS
Regeneron Healthcare Solutions, Inc. $29.9104/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212868994 CMS
ANI Pharmaceuticals, Inc. $2.8104/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248585830 CMS
ANI Pharmaceuticals, Inc. $5.1804/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248593193 CMS
GENZYME CORPORATION $34.6404/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233229031 CMS
Electromed, Inc. $3.6804/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224580110 CMS
AstraZeneca Pharmaceuticals LP $14.7704/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206845123 CMS
Merck Sharp & Dohme LLC $23.9903/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238314610 CMS
Actelion Pharmaceuticals US, Inc. $9.7403/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174171955 CMS
GlaxoSmithKline, LLC. $18.1703/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191230120 CMS
United Therapeutics Corporation $25.9903/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242541546 CMS
ANI Pharmaceuticals, Inc. $28.2703/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248596829 CMS
GlaxoSmithKline, LLC. $24.6103/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190659196 CMS
GlaxoSmithKline, LLC. $17.9703/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191147126 CMS
Verona Pharma, Inc. $24.8503/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233750644 CMS
Axsome Therapeutics, Inc. $111.0003/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235792358 CMS
AstraZeneca Pharmaceuticals LP $16.7003/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206346527 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.0403/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223882047 CMS
HARMONY BIOSCIENCES LLC $6.9603/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222400826 CMS
Insmed, Inc. $26.7403/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186315297 CMS
Lilly USA, LLC $16.2703/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186605836 CMS
Actelion Pharmaceuticals US, Inc. $29.4903/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174173122 CMS
Electromed, Inc. $17.9003/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224580146 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.4903/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223008652 CMS
Axsome Therapeutics, Inc. $14.3503/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235761566 CMS
Actelion Pharmaceuticals US, Inc. $29.1902/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174173883 CMS
Mallinckrodt Hospital Products Inc. $17.3802/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211950873 CMS
ZOLL Respicardia, Inc. $24.0702/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237522617 CMS
GlaxoSmithKline, LLC. $14.1002/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190648208 CMS
Avadel CNS Pharmaceuticals, LLC $30.3102/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208531749 CMS
Regeneron Healthcare Solutions, Inc. $36.9102/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212868992 CMS
Axsome Therapeutics, Inc. $33.2002/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235387533 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.3202/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223008650 CMS
Verona Pharma, Inc. $30.3602/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233750654 CMS
Electromed, Inc. $3.9402/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224580106 CMS
AstraZeneca Pharmaceuticals LP $20.0002/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206361799 CMS
GlaxoSmithKline, LLC. $14.0102/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190703152 CMS
ABIOMED $18.6002/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174389697 CMS
Viatris Specialty LLC $29.6302/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238489720 CMS
Actelion Pharmaceuticals US, Inc. $28.2502/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174172183 CMS
AstraZeneca Pharmaceuticals LP $16.0202/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206853080 CMS
Amgen Inc. $18.1002/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228270151 CMS
INOGEN, INC. $11.2602/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253657763 CMS
Electromed, Inc. $13.7902/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224580155 CMS
GENZYME CORPORATION $27.3302/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233229019 CMS
Inspire Medical Systems, Inc. $17.8702/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251448308 CMS
Actelion Pharmaceuticals US, Inc. $30.2601/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174173197 CMS
Baxter Healthcare $21.0201/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1180962876 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,965.48 128
PY2020 $2,235.97 47
PY2021 $1,482.06 81
PY2022 $3,165.61 162
PY2023 $3,950.65 167
PY2024 $4,903.19 210
PY2025 $5,215.10 213

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $224,812.42 11
PY2024 Principal investigator $320,673.04 9
PY2023 Principal investigator $296,439.74 9
PY2022 Principal investigator $341,007.65 10
PY2021 Principal investigator $133,409.51 12
PY2020 Principal investigator $382,168.86 2
PY2019 Principal investigator $436,933.41 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $14,014.15 12/31/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Heart Failure with Preserved Ejection Fraction HFpEF No dispute reported 06/30/2026 1232917507
Principal investigator 1 Merck Sharp & Dohme LLC $4,793.54 12/31/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Heart Failure with Preserved Ejection Fraction HFpEF No dispute reported 06/30/2026 1232917509
Principal investigator 1 Merck Sharp & Dohme LLC $90,059.73 12/31/2025 Non-covered Recipient Entity
PULMONARY ASSOCIATES, P.A.
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Heart Failure with Preserved Ejection F No dispute reported 06/30/2026 1232917559
Principal investigator 1 Merck Sharp & Dohme LLC $11,829.50 12/31/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
A Phase 2, Multicenter, Single-blinded, Randomized Study to Evaluate the Pharmacokinetics and Safety of Sotatercept MK-7962 Administered Using Either a Weight-based or Weight-banded Approach in Participants With Pulmonary Arterial Hypertension PAH on No dispute reported 06/30/2026 1232938774
Principal investigator 1 Merck Sharp & Dohme LLC $19,869.90 12/31/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy for the Treatment of PAH MK-7962-038 No dispute reported 06/30/2026 1232938918
Principal investigator 1 Merck Sharp & Dohme LLC $6,496.56 12/31/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy for the Treatment of PAH MK-7962-038 No dispute reported 06/30/2026 1232938920
Principal investigator 1 Merck Sharp & Dohme LLC $40,633.40 12/15/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Heart Failure with Preserved Ejection Fraction HFpEF No dispute reported 06/30/2026 1232917533
Principal investigator 1 Merck Sharp & Dohme LLC $11,674.32 12/10/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy for the Treatment of PAH No dispute reported 06/30/2026 1232917563
Principal investigator 1 Merck Sharp & Dohme LLC $16,300.00 11/24/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy for the Treatment of PAH MK-7962-038 No dispute reported 06/30/2026 1232938916
Principal investigator 1 Merck Sharp & Dohme LLC $8,000.00 07/01/2025 Non-covered Recipient Entity
Pulmonary Associates, PA
A Phase 2, Multicenter, Single-blinded, Randomized Study to Evaluate the Pharmacokinetics and Safety of Sotatercept MK-7962 Administered Using Either a Weight-based or Weight-banded Approach in Participants With Pulmonary Arterial Hypertension PAH on No dispute reported 06/30/2026 1232938772
Principal investigator 1 Merck Sharp & Dohme LLC $1,141.32 03/10/2025 Non-covered Recipient Entity
PULMONARY ASSOCIATES, P.A.
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Heart Failure with Preserved Ejection F No dispute reported 06/30/2026 1232917561